A Smart + Strong Site
Subscribe to:
POZ magazine

Back to home » Treatment News » Top Stories

September 30, 2014
Monkey Study Suggests Radiation Didn't Cure 'Berlin Patient' of HIV
A primate study has suggested that the radiation part of the leukemia treatment the “Berlin patient” received was not what functionally cured him of HIV.
September 29, 2014
Just Half of HIV-Diagnosed Gay and Bi Men Receive Treatment
Only one in two gay or bisexual men diagnosed with HIV receive care and treatment for the virus, and only 42 percent are virally suppressed.
September 26, 2014
Gay Men, Especially Youths, Are Tuned Out Where HIV Is Concerned
A new national survey paints in stark statistics the image of a gay and bisexual population that is largely unconcerned about HIV, unaware that antiretrovirals can prevent infection and dismissive of men living with the virus as potential love or sexual interests.
September 25, 2014
FDA Approves Gilead’s Vitekta (Elvitegravir) to Treat HIV
The FDA has approved Gilead Sciences’ integrase strand transfer inhibitor Vitekta (elvitegravir) for treatment-experienced HIV-positive adults.
FDA Approves HIV Treatment Boosting Agent Tybost (Cobicistat)
The FDA has approved Gilead's Tybost (cobicistat) as a boosting agent to raise the drug levels of Reyataz (atazanavir) or Prezista (darunavir) in combination with other antiretrovirals (ARVs) to treat HIV.
September 24, 2014
HIV-Positive People in Care Are Infrequently Retested for Hep C
While people with HIV are typically tested for hepatitis C upon entering care, follow-up hep C screens are less common.
September 23, 2014
Drug Use Strongly Linked to Risky Sex Among Gay Brits With HIV
A survey of gay men with HIV who attended sexual health clinics in England has found a strong correlation between drug use and higer-risk sex.
September 22, 2014
Americans Adhered Well to PrEP in Global iPrEx Study
A new analysis of the global iPrEx trial has found that American participants adhered relatively well to Truvada as pre-exposure prophylaxis (PrEP). 
September 19, 2014
Targeting PrEP to High-Risk Gays Would Lower HIV—For a Huge Price
Targeting Truvada as PrEP to New York City men who have sex with men at high risk for HIV is the most cost-effective approach to promoting the intervention.
September 18, 2014
Tenofovir Tied to Kidney Damage in Those With Low Body Weight
There is an apparent link between taking Viread (tenofovir) and developing kidney damage among HIV-positive people with low body weight.
September 17, 2014
Injection Drug Use Disproportionately Drives HIV in Puerto Ricans
Puerto Ricans are disproportionately affected by HIV in the U.S. when compared with the overall Latino population, with injection drug use a major driver.
September 16, 2014
HIV Combo Pill Less Toxic Thanks to New Form of Tenofovir
An investigational single-tablet combination regimen to treat HIV has comparable efficacy to and is less toxic than a similar regimen of individual tablets, thanks to the new form of tenofovir in the combo pill.
September 15, 2014
Educational Video Successfully Encourages HIV Testing in ER
A 16-minute educational video on HIV testing increased emergency room visitors’ testing willingness by a third in a recent study funded by the National Institute on Drug Abuse.
High Hep C Cure Rates for '3D' Combo in People Coinfected With HIV
AbbVie’s “3D” regimen cured high rates of genotype 1 of hepatitis C virus (HCV) among people coinfected with HIV.
September 12, 2014
Syphilis Is on the Rise Among Gay and Bi Men in Vancouver, BC
Syphilis rates have been increasing in Vancouver, British Columbia, especially among men who have sex with men.
September 11, 2014
Atripla Is More Than the Sum of Its Three Parts
People taking Atripla reach virologic failure more slowly and are less likely to develop drug resistance than those taking an equivalent combination therapy as separate pills. 
September 10, 2014
Greater Clarity to How HIV May Lead to Cognitive Decline
HIV damages the brain, likely leading to cognitive decline, by infecting white blood cells that enter the organ and set off a harmful immune response.
September 09, 2014
Flu Shots Work for Pregnant Women Regardless of HIV Status
The influenza vaccine is just as effective for pregnant women living with HIV as for those without the virus.
September 08, 2014
New Meningitis Cases Found in HIV-Positive Gay and Bi Men in NYC
Three gay or bisexual men, all of them HIV positive and in New York City, have contracted invasive meningococcal disease since August 24, in an apparent resurgence of the 2010 to 2013 outbreak.
HIV-Negative Gay Men May Acquire Hepatitis C Sexually
HIV-negative men who have sex with men (MSM) are apparently at risk for sexual acquisition of hepatitis C.
September 05, 2014
New HIV Antibody Target Could Aid a Vaccine, Treatment or PrEP
The discovery of a site on HIV’s surface that is vulnerable to a powerful antibody could lead to developments in the treatment, prevention and vaccine fields.
September 04, 2014
Fungus Hazardous to People With HIV Found to Grow on Trees in SoCal
Researchers have pinpointed the source of a fungus that’s long been sickening HIV-positive people in Southern California: It grows on trees.
September 03, 2014
Selzentry Dosing May Be Inadequate for HIV-Positive Blacks
HIV-positive African Americans may not be able to maintain effective drug levels of Selzentry (maraviroc) at the antiretroviral’s standard dose, thanks to a protein that is more common in blacks than among whites.
September 02, 2014
Monkey HIV Vaccine Success Opens Door for Human Trials
A new HIV vaccine approach has proved highly successful at blocking SIV, HIV’s virus simian cousin, among rhesus macaques.
Most Popular Stories
Undetectable Viral Load Essentially Eliminates Transmission Risk in Straight Couples
A 15-Year Jump in Life Expectancy for People With HIV
Life Expectancy for Young People With HIV Is Nearly Normal
Failure to Awaken Dormant Cells Deals Blow to HIV Cure Research
Scientists Devise Method of Snipping HIV From Immune Cells
Media Cooks Up Claim That Soy Sauce Treats, Even Cures HIV
FDA Approves New Single-Tablet HIV Regimen, Triumeq
Most Popular Lessons
Aging & HIV
The HIV Life Cycle
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?

September 2014
August 2014
July 2014
June 2014
May 2014
April 2014
March 2014
February 2014
January 2014
December 2013
November 2013
October 2013
September 2013
August 2013
July 2013
June 2013
May 2013
April 2013
March 2013
February 2013
January 2013
December 2012
November 2012
October 2012
September 2012
August 2012
July 2012
June 2012
May 2012
April 2012
March 2012
February 2012
January 2012
December 2011
November 2011
October 2011
September 2011
August 2011
July 2011
June 2011
May 2011
April 2011
March 2011
February 2011
January 2011
December 2010
November 2010
October 2010
September 2010
August 2010
July 2010
June 2010
May 2010
April 2010
March 2010
February 2010
January 2010
December 2009
November 2009
October 2009
September 2009
August 2009
July 2009
June 2009
May 2009
April 2009
March 2009
February 2009
January 2009
December 2008
November 2008
October 2008
September 2008
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
January 2008
December 2007
November 2007
October 2007
September 2007
August 2007
July 2007
June 2007
May 2007
April 2007
March 2007
February 2007
January 2007
December 2006
November 2006
October 2006
September 2006
August 2006
July 2006
June 2006
May 2006
April 2006
February 2006
October 2005

Quick Links
AIDSmeds en Español
About HIV and AIDS
Lab Tests
Clinical Trials
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Conference Coverage
Health Services Directory
POZ Magazine

    Long Beach



    New York
Click here to join POZ Personals!
Conference Coverage

XX International AIDS Conference
(AIDS 2014)
Melbourne, Australia
July 20 - 25, 2014

21st Conference on Retroviruses and Opportunistic Infections
(CROI 2014)
Boston, MA
March 3 - 7, 2014

7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention
(IAS 2013)
Kuala Lumpur, Malaysia
June 30 - July 3, 2013

more conference coverage

[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.